Kryptos Biotechnologies

3423 Investment Blvd. Suite 6
Hayward,  CA  94545

United States
https://kryptosbio.com/

• Booth: 3622

Kryptos Biotechnologies is developing Kuick, a rapid, accurate, easy-to-use and affordable molecular diagnostic system for point-of-care testing. The system uses proprietary Ultrafast Photonic PCR technology combined with sold-phase extraction in the sample preparation. The system ensures the best-in-class performance while providing test results on time. The development of the system is completed and ready for validation study or clinical study.

 Press Releases

• Kryptos Raises $10 Million in Series A Financing for Clinical Studies & FDA (Apr 08, 2024)
  Kryptos Raises $10 Million in Series A Financing for Clinical Studies & FDA Approval for Molecular Diagnostics System

 Additional Info